Indegene shares bought by Sunil Singhanias Abakkus, other major funds in Wednesdays block - CNBC TV18
Summary
A large block deal in Indegene changed hands on Wednesday, with several institutional buyers acquiring shares from Carlyle’s CA Dawn Investments. Carlyle fully exited its stake through the transaction. The deal covered 2.53 crore shares, or 10.56% of the company’s outstanding equity, at an average price of 591 per share. Indegene’s stock fell 4% on the day and remains above its IPO price but below its post-listing peak.
Classifications
industries
HealthTech
applications
Web and Content Management
AskAI Classifications
Labels
Life Sciences Software
Healthcare Digital Solutions
SaaS
Linked Companies
Indegene
$100M to $250M